Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Xinying Biomedical Technology
Suzhou, Jiangsu, China
- Ownership
- Private
- Development stage
- Other
01
Overview
The company's platform uses rare earth colloidal nanoparticles with dual MRI and NIR-II fluorescence imaging to rapidly identify metastatic sentinel lymph nodes intraoperatively. Published animal research demonstrated successful, rapid, and precise intraoperative node identification and resection, suggesting promise for further development in precision cancer surgery[13].
- Therapeutic areas
- Oncology
- Modalities
- NanoparticleDiagnostic agentImaging agent
- Industry
- Medical Imaging
Beyond the preview
Go deeper on Suzhou Xinying Biomedical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suzhou Xinying Biomedical Technology.